Get informed when a big investor buys or sells
+ Follow26.80
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
M3 (MTHRF) currently reports a P/E ratio of 26.8. That is below the Healthcare sector average of 70.94. Use the charts on this page to explore M3's P/E ratio history and peer comparisons.
M3's P/E ratio of 26.8 is lower than the Healthcare sector average of 70.94. That is roughly 62.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates M3's market price to a fundamental measure such as earnings, sales, or book value. At 26.8, MTHRF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 26.8, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for M3, and consider following MTHRF for alerts when major investors trade the stock.
M3 is classified in the Healthcare sector. On P/E ratio, it currently shows 26.8 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MTHRF with unrelated industries.